ARIH1 and breast cancer: The analysis reveals that higher expression levels of TSPYL5, ATP5E, CA9, NUP210, SLC37A1, ARIH1, PSMD7, UBQLN1, PRAME, and UBE2T are associated with an increased risk of BC metastasis.